{"id":4034,"date":"2026-02-05T17:26:14","date_gmt":"2026-02-05T16:26:14","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/?p=4034"},"modified":"2026-02-23T13:46:02","modified_gmt":"2026-02-23T12:46:02","slug":"4034","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/4034\/","title":{"rendered":"FHU Spring General Assembly"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">LIEU : H\u00f4pital Bic\u00eatre, b\u00e2timent Fran\u00e7oise Barr\u00e9-Sinoussi, secteur orange, Porte 40, RdC, salle staff<\/h3>\n\n\n\n<h2 class=\"wp-block-heading\">PROGRAMME <\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">OUVERTURE \/ INTRODUCTION<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Samuel Bitoun, Xavier Mariette, L\u00e9o Pla\u00e7ais<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">I- INNOVATE &#8211; Nouveaux outils et approches innovantes<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>\u00c9pid\u00e9miologie REISAMIC <\/em>\u2013 Lucas Pacoureau <em><br>Interception : pr\u00e9vention 2.0 des cancers <\/em>\u2013 Pamela Abdayem&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Organo\u00efdes de glandes salivaires : vers l\u2019immuno-organo\u00efdes <\/em>\u2013 Lo\u00efc Meudec<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">II- UNDERSTAND &#8211; Nouveaux m\u00e9canismes immunologiques<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Ciblage mitochondrial des cellules CAR T pour optimiser les immunoth\u00e9rapies <\/em>\u2013 Emmanuel Donnadieu&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>R\u00f4le des IFN-I dans la DM juv\u00e9nile: h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 clinique et pathog\u00e9n\u00e8se <\/em>\u2013 Thomas Moreau<br><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">III- TREAT &#8211; Nouveaux traitements<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>D\u00e9pl\u00e9tion lymphocytaire B dans des TCE ciblant BCMA <\/em>\u2013 Jeanne Gauthier<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>Maximum prednisone dose above20 mg to treatrheumatologicsideeffectsof immune checkpoints isassociatedwithshorter cancer survival<\/em>\u2013 Samuel Bitoun<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">IV- TEACH &#8211; \u00c9ducation et diffusion des connaissances<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>International Summer SchoolCAR T cellsin AID <\/em>\u2013 Bitoun S.\/ Bigenwald C.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>TransdisciplinaryImmunology Journal Club <\/em>\u2013 Bitoun S. \/ Danlos FX&nbsp;<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">CONCLUSION<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mot de la fin<\/li>\n<\/ul>\n\n\n\n<p class=\"has-text-align-right\"><em>Format : 20 min par intervention (15\u2019 expos\u00e9 + 5\u2019 \u00e9changes).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>LIEU : H\u00f4pital Bic\u00eatre, b\u00e2timent Fran\u00e7oise Barr\u00e9-Sinoussi, secteur orange, Porte 40, RdC, salle staff PROGRAMME OUVERTURE \/ INTRODUCTION I- INNOVATE &#8211; Nouveaux outils et approches innovantes II- UNDERSTAND &#8211; Nouveaux m\u00e9canismes immunologiques III- TREAT &#8211; Nouveaux traitements IV- TEACH &#8211; \u00c9ducation et diffusion des connaissances CONCLUSION Format : 20 min par intervention (15\u2019 expos\u00e9 + [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4035,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-post-left-featured-image","format":"standard","meta":{"event_date":"Monday, 16 March 2026","event_location":"H\u00f4pital Bic\u00eatre","event_time":"14h-17h","footnotes":""},"categories":[10],"tags":[],"class_list":["post-4034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/4034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=4034"}],"version-history":[{"count":3,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/4034\/revisions"}],"predecessor-version":[{"id":4472,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/4034\/revisions\/4472"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/4035"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=4034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=4034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=4034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}